• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.69% Nasdaq Up2.12%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    14.09 0.52(3.83%) Dec 17, 4:00PM EST
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):1.9
    Mean Recommendation (last week):1.9
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:24.15
    Median Target:24.00
    High Target:32.00
    Low Target:12.00
    No. of Brokers:13

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Sep 8, 2014FBR CapitalDowngradeMkt PerformUnderperform
    Aug 14, 2014FBR CapitalInitiated Mkt Perform
    Mar 21, 2014MizuhoInitiated Buy
    Dec 13, 2012Maxim GroupInitiated Buy
    Nov 13, 2012Burrill Institutional ResearchInitiated Mkt Outperform
    May 10, 2012Ladenburg ThalmannUpgradeNeutralBuy
    Apr 3, 2012Ladenburg ThalmannDowngradeBuyNeutral
    May 17, 2011OppenheimerInitiated Outperform
    May 6, 2011MLV CapitalInitiated Buy
    Mar 16, 2011JMP SecuritiesInitiated Mkt Outperform

    More Upgrades & Downgrades for KERX

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy4444
    Buy7777
    Hold0001
    Underperform0000
    Sell1110

    Data provided by Thomson/First Call


    Currency in USD.